Early clinical observation of supra‐hemodiafiltration with endogenous reinfusion in the treatment of uremic pruritus

Author:

Zha Fei1,Li Wenwen1,Shi Chunhua1,Deng Yanyan1,Shen Jianming1ORCID

Affiliation:

1. Department of Nephrology Renmin Hospital Hubei University of Medicine Shiyan China

Abstract

AbstractBackgroundTo evaluate the clinical efficacy of supra‐hemodiafiltration with endogenous reinfusion (Supra‐HFR) for pruritus in uremic maintenance hemodialysis (HD) patients and explore the possible mechanism.MethodsThis study prospectively included 60 patients with uremia who underwent maintenance hemodialysis and developed pruritus. Patients were randomly divided into a study group (30 cases) and a control group (30 cases). Patients in the study group underwent dialysis once a week with Supra‐HFR and twice a week with HD. The group received HD dialysis 3 times a week. Visual analog scales (VAS) scores, 5‐D itch scale scores, and 12‐Item Pruritus Severity Scale (12‐PSS) were used to evaluate the itching degree of patients. Quality of life was assessed using KDTA and SF‐36 scores. Blood levels of hypersensitive C‐reactive protein, calcium ion (Ca2+), phosphorus ion (P3+), free parathyroid hormone (iPTH), and β2‐microglobulin (β2‐MG) were compared between the two groups before treatment and at follow‐up 24 weeks after treatment.ResultsBefore treatment, there was no significant difference in VAS, 5‐D itch scale, and 12‐PSS score between the study group and the control group (all p > 0.05). After 24 weeks of treatment, the VAS score of the study group (2.82 ± 0.91) was significantly lower than that of the control group (7.47 ± 1.32, p < 0.001), the 5‐D itch scale score of the study group (9.47 ± 2.34) was significantly lower than that of the control group (18.53 ± 4.02, p < 0.001), the 12‐PSS score of the study group (11.20 ± 1.81) was significantly lower than that of the control group (16.47 ± 2.09, p < 0.001). KDTA of the study group (64.17 ± 8.07 vs. 47.83 ± 13.46, p < 0.001) and SF‐36 scores (65.37 ± 6.28 vs. 55.90 ± 14.28, p = 0.002) were significantly higher than that in the control group. The levels of hs‐CRP, P3+, iPTH, and β2‐MG in the study group after treatment were lower than those before treatment, and lower than those in the control group after treatment (all p < 0.05).ConclusionsThe Supra‐HFR can effectively reduce the itching symptoms of uremia patients and improve their quality of life.

Publisher

Wiley

Subject

Biomedical Engineering,General Medicine,Biomaterials,Medicine (miscellaneous),Bioengineering

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3